Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2025

Feb 11, 2025

33003_dirs_2025-02-11_a2772824-327f-47a3-8857-d9cdeb6dc2e3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2025-01-31

Reporting Person: Brooks Gabriel (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-01-31 Restricted Stock Units $ A 112900 Acquired Common Stock (112900) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 15131 Direct

Footnotes

F1: Includes 4,152 shares of the issuer's common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 29, 2024.

F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").

F3: The RSUs were granted on the January 31, 2025 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.